Sarcopenic obesity

This completed phase 3 trial tested whether a lifestyle program (diet and exercise) plus the drug metformin could reverse frailty and sarcopenic obesity in 114 older veterans aged 65-85. Participants followed a weight-loss diet and exercised three times a week, while taking metfo…

This trial tests whether adding a daily whey protein supplement to an exercise program helps adults aged 65 and older who have sarcopenic obesity, a condition marked by excess fat and low muscle mass. Participants follow a calorie-restricted diet and either receive whey protein o…

This pilot study tests whether a mobile app called EatWelLog can help older adults with sarcopenic obesity — a condition of low muscle and high body fat — better manage their diet and exercise. Forty participants aged 65 and older will use the app alongside an 8-week supervised p…

This study explores whether combining a high-protein Mediterranean diet with resistance exercise can help people with heart disease build muscle and lower their risk of future heart problems. The trial enrolls adults who have completed cardiac rehab and may have low muscle mass w…

This study tests whether a 24-week at-home exercise program using resistance bands while seated in a chair can improve balance, strength, and bone density in adults aged 50 and older. Participants will perform nine different exercises twice a week. The goal is to see if this appr…

This study tested whether taking a high dose of vitamin D3 daily for 12 weeks could improve muscle strength and mass in older adults with obesity. Researchers enrolled 29 participants aged 60 and older in southern Mexico. They measured handgrip strength, muscle mass, and physical…

This pilot study from the University of Aberdeen is looking at how dietary protein (from plants and animals) relates to sarcopenic obesity—a condition where muscle loss and obesity happen together—in 30 women aged 55+ with COPD. Researchers will also check lung function and infla…

This completed study from Fudan University looked at 200 older adults with COPD who also have sarcopenic obesity — a condition where muscle loss and excess fat occur together. Researchers used a device called InBody S10 to measure body composition and phase angles, aiming to buil…

This study followed 1100 adults with severe obesity who took WEGOVY (semaglutide) for 12 months. Researchers collected data on weight, eating habits, and blood markers to see how the drug worked in different groups. The goal is to use this information, along with artificial intel…